Companies: 10,795·Total market cap: $144.5T
Plandaí Biotechnology, Inc.

Plandaí Biotechnology, Inc.

PLPLOTCFinancial Services● Active
$0.00
+$0.00(+900.00%)
Market Cap$4488953
P/E Ratio—
52W High$0.0001
52W Low$0.00001
Overview

Plandaí Biotechnology, Inc. (PLPL) · Cash Flow

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · PLPL · as of 2026-06-10

Financial statements

Operating CF · CapEx · Free Cash Flow
Breakdown2024-062023-062022-062021-062020-06
Operating Activities
Net Income$0.02B($0.02B)$0.01B$0.00B($0.00B)
Depreciation & Amort.$0.00B$0.00B$0.00B$0.00B$0.00B
Stock-Based Comp.$0.00B$0.00B$0.00B$0.00B$0.00B
Change in Working Capital($0.00B)($0.00B)$0.00B$0.00B$0.00B
Net Cash from Operations$0.02B$0.00B$0.01B($0.00B)$0.00B
Investing Activities
Capital Expenditure($0.00B)$0.00B$0.00B$0.00B$0.00B
Purchases of Investments($0.00B)$0.00B$0.00B$0.00B$0.00B
Sales of Investments$0.00B$0.00B$0.00B$0.00B$0.00B
Net Cash from Investing($0.00B)$0.00B$0.00B$0.00B$0.00B
Financing Activities
Common Stock Repurchased($0.00B)$0.00B$0.00B$0.00B$0.00B
Dividends Paid$0.00B$0.00B$0.00B$0.00B$0.00B
Debt Issued / Repaid$0.00B($0.00B)$0.00B$0.00B$0.00B
Net Cash from Financing($0.02B)$0.02B$0.00B$0.00B$0.00B
Free Cash Flow
Free Cash Flow$0.02B$0.00B$0.01B($0.00B)$0.00B
FCF Margin %(computed)—————

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B

SEC 10-K filings →SEC 10-Q filings →

Explore more Plandaí Biotechnology, Inc. data

Revenue History
Quarterly & annual revenue trends
Earnings Reports
EPS beats, misses & upcoming dates
P/E Ratio
Historical price-to-earnings
Dividends
Dividend history & yield
Market Cap
Historical market cap & rank
Analyst Forecast
Consensus, price targets & estimates

About Plandaí Biotechnology, Inc. (PLPL) Cash Flow Statement

Plandaí Biotechnology, Inc. generated operating cash flow of $0.02B and free cash flow of $0.02B for 2024 — a FCF margin of —. Capital expenditure was ($0.00B).

Frequently asked questions

PLPL · 4 questions

Plandaí Biotechnology, Inc. generated free cash flow of $0.02B for 2024, up 2702.3% year-over-year.

PLPL free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10